Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase.
J Oncol Pharm Pract
; : 10781552221113578, 2022 Jul 13.
Article
in En
| MEDLINE
| ID: mdl-35833221
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2022
Type:
Article
Affiliation country:
South Africa